Migraine and stroke: A complex association with clinical implications

The Lancet Neurology

Volumn 11, Issue 1, 2012, Pages 92-100

  Kurth, Tobias ^c,d   Chabriat, Hugues ^a,b   Bousser, Marie Germaine ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DIPEPTIDYL CARBOXYPEPTIDASE; ERGOT DERIVATIVE; ERGOTAMINE; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; SUMATRIPTAN; TRIPTAN DERIVATIVE; VASOCONSTRICTOR AGENT;

BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN STEM; CARDIOVASCULAR RISK; CEREBELLUM; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; FAMILY HISTORY; HUMAN; META ANALYSIS (TOPIC); MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SMOKING; SPREADING CORTICAL DEPRESSION; TRANSIENT ISCHEMIC ATTACK; UNSPECIFIED SIDE EFFECT; WHITE MATTER;

BRAIN; HUMANS; MIGRAINE DISORDERS; RISK FACTORS; STROKE;

EID: 83455253439     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70266-6     Document Type: Review

References (113)

1. Féré C Note sur un cas de migraine ophtalmique à accès répétés suivis de mort. Rev Med (Paris) 1883, 3:194-201. (in French).
2. Bousser MG, Welch KM Relation between migraine and stroke. Lancet Neurol 2005, 4:533-542.
3. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984, 16:481-488.
4. Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993, 3:256-259.
5. Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser MG Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004, 61:1237-1240.
6. Terwindt GM, Haan J, Ophoff RA, et al. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 1998, 121:303-316.
7. Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993, 116:187-202.
8. Swartz RH, Kern RZ Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004, 61:1366-1368.
9. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291:427-434.
10. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006, 37:1109-1112.
11. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009, 301:2563-2570.
12. Kurth T, Mohamed S, Maillard P, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ 2011, 342:c7357.
13. Tzourio C, Iglesias S, Hubert JB, et al. Migraine and risk of ischaemic stroke: a case-control study. BMJ 1993, 307:289-292.
14. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005, 64:1020-1026.
15. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005, 64:1573-1577.
16. Kurth T, Kase CS, Schurks M, Tzourio C, Buring JE Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ 2010, 341:c3659.
17. Chang CL, Donaghy M, Poulter N Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999, 318:13-18.
18. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE Migraine and risk of cardiovascular disease in women. JAMA 2006, 296:283-291.
19. Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010, 74:628-635.
20. Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 2010, 341:c3966.
21. The international classification of headache disorders, 2nd edn. Cephalalgia 2004, 24(suppl 1):9-160. Headache Classification Subcommittee of the International Headache Society.
22. Ferrari MD Migraine. Lancet 1998, 351:1043-1051.
23. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989, 25:382-390.
24. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA Glial and neuronal control of brain blood flow. Nature 2010, 468:232-243.
25. Associated risk factors. JAMA 1975, 231:718-722. Oral contraceptives and stroke in young women.
26. Henrich JB, Horwitz RI A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 1989, 42:773-780.
27. MacClellan LR, Giles WH, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: The Stroke Prevention in Young Women Study. Stroke 2007, 38:2438-2445.
28. Etminan M, Takkouche B, Isorna FC, Samii A Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005, 330:63.
29. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009, 339:b3914.
30. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010, 123:612-624.
31. Donaghy M, Chang CL, Poulter N Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002, 73:747-750.
32. Kurth T, Schurks M, Logroscino G, Buring JE Migraine frequency and risk of cardiovascular disease in women. Neurology 2009, 73:581-588.
33. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995, 310:830-833.
34. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005, 64:614-620.
35. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009, 72:1864-1871.
36. Rist PM, Tzourio C, Kurth T Associations between lipid levels and migraine: cross-sectional analysis in the Epidemiology of Vascular Ageing Study. Cephalalgia 2011, 31:1459-1465.
37. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008, 337:a636.
38. Schurks M, Zee RY, Buring JE, Kurth T Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 2008, 71:505-513.
39. Pezzini A, Grassi M, Del Zotto E, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 2007, 38:3145-3151.
40. Schurks M, Kurth T, Ridker PM, Buring JE, Zee RY Association between polymorphisms in the β2-adrenoceptor gene and migraine in women. Headache 2009, 49:235-244.
41. Schurks M, Rist PM, Kurth T MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache 2010, 50:588-599.
42. Schurks M, Buring JE, Ridker PM, Chasman DI, Kurth T Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS One 2011, 6:e22106.
43. Vanmolkot FH, Van Bortel LM, de Hoon JN Altered arterial function in migraine of recent onset. Neurology 2007, 68:1563-1570.
44. Pezzini A, Grassi M, Lodigiani C, et al. Predictors of migraine subtypes in young adults with ischemic stroke: the Italian Project on Stroke in Young Adults. Stroke 2010, 42:17-21.
45. Rist PM, Buring JE, Kase CS, Schurks M, Kurth T Migraine and functional outcome from ischemic cerebral events in women. Circulation 2010, 122:2551-2557.
46. Russell MB, Ducros A Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011, 10:457-470.
47. Skoloudik D, Kral M, Sanak D, et al. Thrombolytic treatment of ischaemic stroke occurring during a migrainous attack: a case report. Cephalalgia 30: 368-72.
48. Fisher CM Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980, 7:9-17.
49. Izenberg A, Aviv RI, Demaerschalk BM, et al. Crescendo transient aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke 2009, 40:3725-3729.
50. Lashley KS Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 1941, 46:331-339.
51. Leão AAP, Morison RS Propagation of spreading cortical depression. J Neurophysiol 1945, 8:33-45.
52. Leão AA Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol 1947, 10:409-414.
53. Olesen J, Larsen B, Lauritzen M Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981, 9:344-352.
54. Lauritzen M, Skyhoj Olsen T, Lassen NA, Paulson OB Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983, 13:633-641.
55. Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab 2011, 31:17-35.
56. Dreier JP The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011, 17:439-447.
57. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001, 98:4687-4692.
58. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 2001, 50:582-587.
59. Goadsby PJ Current concepts of the pathophysiology of migraine. Neurol Clin 1997, 15:27-42.
60. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?. Brain 2002, 125:102-112.
61. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010, 67:221-229.
62. Newman DS, Levine SR, Curtis VL, Welch KM Migraine-like visual phenomena associated with cerebral venous thrombosis. Headache 1989, 29:82-85.
63. Dalkara T, Nozari A, Moskowitz MA Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 2011, 9:309-317.
64. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000, 356:1648-1651.
65. Bousser MG Patent foramen ovale and migraine: evidence for a link?. Headache Currents 2006, 3:44-51.
66. Ratinahirana H, Benigni JP, Bousser MG Injection of polidocanol foam (PF) in varicose veins as a trigger for attacks of migraine with visual aura. Cephalalgia 2003, 23:850-851.
67. 2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
68. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366:371-377.
69. + pump α2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003, 33:192-196.
70. van den Maagdenberg AM, Pizzorusso T, Kaja S, et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol 2010, 67:85-98.
71. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG Cadasil. Lancet Neurol 2009, 8:643-653.
72. Dreier JP, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?. J Neurosurg 2000, 93:658-666.
73. Wolf ME, Szabo K, Griebe M, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011, 76:1911-1917.
74. Rist PM, Diener HC, Kurth T, Schurks M Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia 2011, 31:886-896.
75. Debette S, Markus HS The genetics of cervical artery dissection: a systematic review. Stroke 2009, 40:e459-e466.
76. Tzourio C, El Amrani M, Robert L, Alperovitch A Serum elastase activity is elevated in migraine. Ann Neurol 2000, 47:648-651.
77. Schwedt TJ, Demaerschalk BM, Dodick DW Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008, 28:531-540.
78. Speciali JG, Peres M, Bigal ME Migraine treatment and placebo effect. Expert Rev Neurother 2010, 10:413-419.
79. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005, 91:1173-1175.
80. Buring JE, Peto R, Hennekens CH Low-dose aspirin for migraine prophylaxis. JAMA 1990, 264:1711-1713.
81. Rundek T, Elkind MS, Di Tullio MR, et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 2008, 118:1419-1424.
82. Garg P, Servoss SJ, Wu JC, et al. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation 2010, 121:1406-1412.
83. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008, 117:1397-1404.
84. Roon KI, Bakker D, van Poelgeest MI, van Buchem MA, Ferrari MD, Middelkoop HA The influence of ergotamine abuse on psychological and cognitive functioning. Cephalalgia 2000, 20:462-469.
85. Hall GC, Brown MM, Mo J, MacRae KD Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004, 62:563-568.
86. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, Tijssen CC, Egberts AC Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006, 67:1128-1134.
87. Asghar MS, Hansen AE, Amin FM, et al. Evidence for a vascular factor in migraine. Ann Neurol 2011, 69:635-645.
88. Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA Increased von Willebrand factor in migraine. Neurology 2001, 57:334-336.
89. Soriani S, Borgna-Pignatti C, Trabetti E, Casartelli A, Montagna P, Pignatti PF Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998, 38:779-781.
90. Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 2001, 21:137-139.
91. Moschiano F, D'Amico D, Ciusani E, et al. Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischaemic stroke?. Neurol Sci 2004, 25(suppl 3):S126-S128.
92. Napoli R, Guardasole V, Zarra E, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 2009, 72:2111-2114.
93. Schillaci G, Sarchielli P, Corbelli I, et al. Aortic stiffness and pulse wave reflection in young subjects with migraine: a case-control study. Neurology 2010, 75:960-966.
94. Tietjen GE, Gottwald L, Al-Qasmi MM, Gunda P, Khuder SA Migraine is associated with livedo reticularis: a prospective study. Headache 2002, 42:263-267.
95. Knierim E, Leisle L, Wagner C, et al. Recurrent stroke due to a novel voltage sensor mutation in Cav2.1 responds to verapamil. Stroke 2011, 42:e14-e17.
96. Menon S, Cox HC, Kuwahata M, et al. Association of a Notch 3 gene polymorphism with migraine susceptibility. Cephalalgia 2011, 31:264-270.
97. Eriksen MK, Thomsen LL, Olesen J Implications of clinical subtypes of migraine with aura. Headache 2006, 46:286-297.
98. Haas DC Arteriovenous malformations and migraine: case reports and an analysis of the relationship. Headache 1991, 31:509-513.
99. Chabriat H, Pappata S, Traykov L, Kurtz A, Bousser MG Sturge-Weber angiomatosis responsible for hemiplegia without cerebral infarction in term pregnancy. Rev Neurol (Paris) 1996, 152:536-541. (in French).
100. Park-Matsumoto YC, Tazawa T, Shimizu J Migraine with aura-like headache associated with moyamoya disease. Acta Neurol Scand 1999, 100:119-121.
101. Marziniak M, Jung A, Guralnik V, Evers S, Prudlo J, Geisthoff UW An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts. Cephalalgia 2009, 29:76-81.
102. Krause I, Lev S, Fraser A, et al. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis 2005, 64:1490-1493.
103. Tietjen GE, Al-Qasmi MM, Gunda P, Herial NA Sneddon's syndrome: another migraine-stroke association?. Cephalalgia 2006, 26:225-232.
104. Tjensvoll AB, Harboe E, Goransson LG, et al. Migraine is frequent in patients with systemic lupus erythematosus: a case-control study. Cephalalgia 2011, 31:401-408.
105. de Ceuster L, van Diepen T, Koehler PJ Migraine with aura triggered by cardiac myxoma: case report and literature review. Cephalalgia 2010, 30:1396-1399.
106. Gould DB, Phalan FC, van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006, 354:1489-1496.
107. Stam AH, Haan J, van den Maagdenberg AM, Ferrari MD, Terwindt GM Migraine and genetic and acquired vasculopathies. Cephalalgia 2009, 29:1006-1017.
108. Michiels JJ, Berneman Z, Schroyens W, et al. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Platelets 2006, 17:528-544.
109. Kurth T, Diener HC, Buring JE Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study. Cephalalgia 2011, 31:1106-1115.
110. Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM Does this patient with headache have a migraine or need neuroimaging?. JAMA 2006, 296:1274-1283.
111. Zhu YC, Dufouil C, Tzourio C, Chabriat H Silent brain infarcts: a review of MRI diagnostic criteria. Stroke 2011, 42:1140-1145.
112. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
113. Hedman C, Andersen AR, Andersson PG, et al. Symptoms of classic migraine attacks: modifications brought about by metoprolol. Cephalalgia 1988, 8:279-284.